I am Professor Anskar Leung, one of the founders of ZeBlast Technology Ltd, a biotechnology company dedicated to developing better treatments for patients with ageing-related complications through scientific innovations. As a clinician, I have seen how the elderly patients suffer from the devastations of heart attack, stroke, demantia or cancers. These are leading causes of death in the populations. We believe that these diseases are caused by gene mutation of bone marrow stem cells in the elderly people.

Zebrafish has emerged as a model organism for the study of human diseases. Its genome has been sequenced, with remarkable similarity to that of human. Compared with the mouse model, zebrafish is at least 10 times more cost and space effective.

ZeBlast was founded on a solid foundation with more than 20 years of research experience in zebrafish and disease models. We have successful generated transgenic fish that carry specific human mutations of blood diseases and responded to targeted therapy that are typically effective in patients. These models have been charactierized to ensure faithful recapitulation of human diseases, making them available off-the-shelf for both industrial and academic customers to begin their drug discovery journal almost immediately.

I hope you will join our journey to develop effective treatments for ageing related diseases.

Sincerely,
Professor Anskar Y H Leung